𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Duration of antibiotic treatment in disseminated Lyme borreliosis: a double-blind, randomized, placebo-controlled, multicenter clinical study

✍ Scribed by J. Oksi; J. Nikoskelainen; H. Hiekkanen; A. Lauhio; M. Peltomaa; A. Pitkäranta; D. Nyman; H. Granlund; S.-A. Carlsson; I. Seppälä; V. Valtonen; M. Viljanen


Publisher
Springer
Year
2007
Tongue
English
Weight
226 KB
Volume
26
Category
Article
ISSN
0934-9723

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Sulfasalazine in the treatment of juveni
✍ Marion A. J. van Rossum; Theo J. W. Fiselier; Marcel J. A. M. Franssen; Aeilko H 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 987 KB

Objective. To assess the efficacy, tolerability, and safety of sulfasalazine (SSZ) in the treatment ofjuvenile chronic arthritis (JCA). Methods. We conducted a 24-week randomized, placebo-controlled, double-blind, multicenter study of patients with active JCA of both oligoarticular and polyarticula

Gabapentin in the treatment of fibromyal
✍ Lesley M. Arnold; Don L. Goldenberg; Sharon B. Stanford; Justine K. Lalonde; H. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 168 KB 👁 3 views

## Abstract ## Objective To assess the efficacy and safety of gabapentin in patients with fibromyalgia. ## Methods A 12‐week, randomized, double‐blind study was designed to compare gabapentin (1,200–2,400 mg/day) (n = 75 patients) with placebo (n = 75 patients) for efficacy and safety in treatin

Hypericum treatment of mild–moderate dep
✍ E. Schrader; B. Meier; A. Brattström 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 2 views

A prospective, randomized, multicentre, double-blind placebo controlled study is described which compares the ecacy and tolerability of hypericum administered as a concentrated ethanolic extract of St John's wort (ZE117) to patients with mild±moderate depression (ICD-10; F 32 . 0 mild; F 32 . 1 mode

Results of a multicenter placebo-control
✍ E. M. Lemmel; D. Brackertz; M. Franke; W. Gaus; P. W. Hartl; K. Machalke; H. Mie 📂 Article 📅 1988 🏛 Springer 🌐 English ⚖ 660 KB

In a multicenter placebo-controlled double-blind randomized clinical study, 91 patients with rheumatoid arthritis were given 28 days' treatment with recombinant interferon-gamma (50 micrograms daily for 20 days, then 50 micrograms each second day up to day 28, given by subcutaneous injection). The a